- $2.76bn
- $6.02bn
- $4.22bn
- 64
- 89
- 95
- 96
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 4,028 | 3,840 | 4,101 | 3,595 | 4,216 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,602 | 3,387 | 3,296 | 2,781 | 3,642 |
Operating Profit | 427 | 453 | 805 | 813 | 574 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 274 | 344 | 733 | 817 | 357 |
Provision for Income Taxes | |||||
Net Income After Taxes | 409 | 268 | 570 | 631 | 277 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 409 | 302 | 570 | 631 | 277 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 409 | 302 | 570 | 631 | 277 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.69 | 1.97 | 4.22 | 5.47 | 2.87 |
Dividends per Share |